Publicaciones en las que colabora con JUAN JOSÉ GARCÍA RODRÍGUEZ (17)

2020

  1. Development of a solid formulation containing a microemulsion of a novel artemisia extract with nematocidal activity for oral administration

    Pharmaceutics, Vol. 12, Núm. 9, pp. 1-15

2019

  1. Enhanced nematocidal activity of a novel Artemisia extract formulated as a microemulsion

    Natural Product Communications, Vol. 14, Núm. 6

  2. Enhancement of the Dissolution Rate of Indomethacin by Solid Dispersions in Low-substituted Hydroxypropyl Cellulose

    Indian Journal of Pharmaceutical Sciences, Vol. 81, Núm. 5, pp. 824-833

  3. Submicellar liquid chromatography with fluorescence detection improves the analysis of naproxen in plasma and brain tissue

    Journal of Separation Science, Vol. 42, Núm. 9, pp. 1702-1709

2018

  1. Efficacy, biodistribution, and nephrotoxicity of experimental amphotericin B-deoxycholate formulations for pulmonary aspergillosis

    Antimicrobial Agents and Chemotherapy, Vol. 62, Núm. 7

2017

  1. Improvement of the surface hydrophilic properties of naproxen particles with addition of hydroxypropylmethyl cellulose and sodium dodecyl sulphate: In vitro and in vivo studies

    International Journal of Pharmaceutics, Vol. 529, Núm. 1-2, pp. 381-390

2016

  1. New Multi-Particle Systems for Colon-Targeted Meloxicam

    Journal of Applied Pharmacy, Vol. 8, Núm. 3, pp. 1-3

2015

  1. Efficacy and toxicity evaluation of new amphotericin B micelle systems for brain fungal infections

    International Journal of Pharmaceutics, Vol. 494, Núm. 1, pp. 17-22

  2. Validated RP-HPLC Method for Simultaneous Amoxicillin and Meloxicam Determination in Combined Dosage Forms

    Journal of Pharma Research, Vol. 4, Núm. 11, pp. 355-660

2014

  1. Enhanced bioavailability and anthelmintic efficacy of mebendazole in redispersible microparticles with low-substituted hydroxypropylcellulose

    Drug Design, Development and Therapy, Vol. 8, pp. 1467-1479

2012

  1. Enantiomerical pharmacokinetic prevalence of (+) albendazole sulphoxide in Trichinella spiralis muscle larvae

    Parasitology Research, Vol. 110, Núm. 2, pp. 993-999

2011

  1. Changed crystallinity of mebendazole solid dispersion: Improved anthelmintic activity

    International Journal of Pharmaceutics, Vol. 403, Núm. 1-2, pp. 23-28

2009

  1. The effect of intestinal trichinellosis on oral bioavailability of albendazole in mice

    Parasitology Research, Vol. 105, Núm. 1, pp. 65-70

2003

  1. Bioavailability and efficacy characteristics of two different oral liquid formulations of albendazole

    International Journal of Pharmaceutics, Vol. 250, Núm. 2, pp. 351-358

2001

  1. Improving bioavailability and anthelmintic activity of albendazole by preparing albendazole-cyclodextrin complexes

    Parasite, Vol. 8, pp. S188-S190

1999

  1. Preparation and characterization of albendazole β-cyclodextrin complexes

    Drug Development and Industrial Pharmacy, Vol. 25, Núm. 12, pp. 1241-1248

  2. Quantitative determination of albendazole and its main metabolites in plasma

    Journal of Chromatography B: Biomedical Sciences and Applications, Vol. 723, Núm. 1-2, pp. 265-271